| Northwest Health And Rehabilitation Center | |
| 17600 Cali Dr, Houston, Texas 77090 | |
| (281) 440-9000 | |
| Name | Northwest Health And Rehabilitation Center |
|---|---|
| Location | 17600 Cali Dr, Houston, Texas |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 148 |
| Occupancy Rate | 72.3% |
| Medicare ID (CCN) | 455714 |
| Legal Business Name | Ssc Houston Northwest Operating Company Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1114048683 |
| Organization Name | SSC HOUSTON NORTHWEST OPERATING COMPANY LLC |
| Doing Business As | NORTHWEST HEALTH AND REHABILITATION CENTER |
| Address | 17600 Cali Dr, Houston, TX 77090 |
| Phone Number | 281-440-9000 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| NPI Number | 1275576894 |
| Organization Name | LIVING CENTERS OF TEXAS, INC. |
| Address | 5300 W Sam Houston Pkwy N, Houston, TX 77041 |
| Phone Number | 832-467-6000 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| NPI Number | 1275962870 |
| Organization Name | WICHITA FALLS OPERATING COMPANY LLC |
| Doing Business As | GRACE CARE CENTER |
| Address | 5300 W Sam Houston Pkwy N, Suite 100, Houston, TX 77041 |
| Phone Number | 832-467-6000 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| NPI Number | 1316660970 |
| Organization Name | OAKBEND MEDICAL CENTER |
| Doing Business As | PARADIGM NORTHWEST |
| Address | 17600 Cali Dr, Houston, TX 77090 |
| Phone Number | 281-440-9000 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| NPI Number | 1407576267 |
| Organization Name | NORTHWEST NURSING & REHABILITATION LLC |
| Address | 17600 Cali Dr, Houston, TX 77090 |
| Phone Number | 281-440-9000 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| NPI Number | 1588094387 |
| Organization Name | OVERLAND PARK LTAC OPERATING COMPANY LLC |
| Doing Business As | INDIAN MEADWOS HEALTHCARE CENTER |
| Address | 5300 W Sam Houston Pkwy N, Suite 100, Houston, TX 77041 |
| Phone Number | 832-467-6000 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| NPI Number | 1841369204 |
| Organization Name | SSC HARRIS SPRING BRANCH LLC |
| Doing Business As | SPRING BRANCH HEALTHCARE CENTER |
| Address | 8955 Long Point Rd, Houston, TX 77055 |
| Phone Number | 713-464-7625 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 22.37 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.73 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63.08 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.65 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.73 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.99 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 89.07 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.63 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 31.49 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.01 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 36.92 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.27 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.21 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.91 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 58.21 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 57.93 | 82.93 |
News Archive
According to new research adults with asthma are twice as likely to have heart disease and older asthmatics have an increased risk of cancer.
Bacterin International Holdings, Inc., a developer of anti-infective coatings for medical applications and revolutionary bone graft material, today announced that it has closed its private placement offering raising total gross proceeds of $9.2 million from the sale to accredited investors, including certain of its directors and officers, of shares of its common stock at a purchase price of $1.60 per share, with detachable warrants to purchase one-quarter of one share its common stock (at an exercise price of $2.50 per share) for each share purchased.
Innovative research aimed to possibly rejuvenate brain cells will be explored by six international researchers with the goal of discovering effective drugs for people with early stage Alzheimer's disease and other dementias.
MAP Pharmaceuticals, Inc. today reported results from a pharmacodynamics trial comparing the acute effects on pulmonary artery pressure of LEVADEX, dihydroergotamine mesylate administered intravenously and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration.
Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences, part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness.
› Verified 4 days ago
Sharpview Residence And Rehabilitation Center Location: 7505 Bellerive, Houston, Texas 77036 Phone: (713) 774-9611 | |
Courtyard Nursing And Rehabilitation Location: 7499 Stanwick Dr, Houston, Texas 77087 Phone: (713) 644-8048 | |
Northwest Health And Rehabilitation Center Location: 17600 Cali Dr, Houston, Texas 77090 Phone: (281) 440-9000 | |
Westchase Health And Rehabilitation Center Location: 8820 Town Park Dr, Houston, Texas 77036 Phone: (713) 777-7241 | |
Texas Institute For Clinically Complex Care Location: 10851 Crescent Moon Dr, Houston, Texas 77064 Phone: (281) 955-4100 |